Halozyme Therapeutics
HALO
$33.20
Share price
0.18%
Change (1 day)
-31.26%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Cash on Hand
Cash on Hand as of December 2022 : $0.36 B
According to Halozyme Therapeutics's latest financial reports the company has $0.36 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.36 B | -51.03% |
| 2021-12-31 | $0.74 B | 101.33% |
| 2020-12-31 | $0.36 B | -12.64% |
| 2019-12-31 | $0.42 B | 18.82% |
| 2018-12-31 | $0.35 B | -24.44% |
| 2017-12-31 | $0.46 B | 128.91% |
| 2016-12-31 | $0.20 B | 89.2% |
| 2015-12-31 | $0.10 B | -20.12% |
| 2014-12-31 | $0.13 B | 89.68% |
| 2013-12-31 | $71.5 M | -28.43% |
| 2012-12-31 | $99.9 M | 89.12% |
| 2011-12-31 | $52.82 M | -36.55% |
| 2010-12-31 | $83.25 M | 23.41% |
| 2009-12-31 | $67.46 M | 5.88% |
| 2008-12-31 | $63.71 M | -34.77% |
| 2007-12-31 | $97.67 M | 121.05% |
| 2006-12-31 | $44.18 M | 130.97% |
| 2005-12-31 | $19.13 M | 19.52% |
| 2004-12-31 | $16 M | 33588.39% |
| 2003-12-31 | $0.04 M | -51.14% |
| 2002-12-31 | $0.09 M | 272.22% |
| 2001-12-31 | $0.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.51 B | 6,382.74% | 🇺🇸 USA |
 Pfizer PFE | $22.73 B | 6,165.81% | 🇺🇸 USA |
 Eli Lilly LLY | $3.66 B | 911.40% | 🇺🇸 USA |
 Sanofi SNY | $14.35 B | 3,855.69% | 🇫🇷 France |
 Baxter BAX | $1.67 B | 361.14% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.17 B | -52.91% | 🇺🇸 USA |